Influence of enteric infections on response to oral poliovirus vaccine: A systematic review and meta-analysis

Journal of Infectious Diseases

Volumn 210, Issue 6, 2014, Pages 853-864

  Parker, Edward P K ^a   Kampmann, Beate ^a,b   Kang, Gagandeep ^c   Grassly, Nicholas C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MRC Unit   (Gambia)

^c CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Diarrhea; Enterovirus; Immunogenicity; Interference; Oral poliovirus vaccine

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

CLINICAL TRIAL (TOPIC); CONCURRENT INFECTION; CONFERENCE PAPER; DIARRHEA; ENTEROVIRUS; HUMAN; INTESTINE INFECTION; META ANALYSIS; NONHUMAN; NONPOLIO ENTEROVIRUS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VACCINATION; VIRUS SHEDDING;

DIARRHEA; ENTEROVIRUS; IMMUNOGENICITY; INTERFERENCE; ORAL POLIOVIRUS VACCINE;

DIARRHEA; ENTEROVIRUS INFECTIONS; HUMANS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; VIRUS SHEDDING;

EID: 84907337922     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu182     Document Type: Conference Paper

References (50)

1. Plotkin SA, Lebrun A, Koprowski H. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Belgian Congo. 2. Studies of the safety and efficacy of vaccination. Bull World Health Organ 1960; 22:215-34.
2. Patriarca PA,Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13:926-39.
3. Sabin AB, Michaels RH, Spigland I, Pelon W, Rhim JS, Wehr RE. Community-wide use of oral poliovirus vaccine. Effectiveness of the Cincinnati program. Am J Dis Child 1961; 101:546-67.
4. Global Polio Eradication Initiative. Polio eradication and endgame strategic plan (2013-2018). http://www.polioeradication.org/resourcelibrary/ strategyandwork.aspx. Accessed 3 September 2013.
5. Su-Arehawaratana P, Singharaj P, Taylor DN, et al. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J Infect Dis 1992; 165:1042-8.
6. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
7. Serazin AC, Shackelton LA,Wilson C, Bhan MK. Improving the performance of enteric vaccines in the developing world. Nat Immunol 2010; 11:769-73.
8. Benyesh-Melnick M, Melnick JL, Ramos-Alvarez M. Poliomyelitis infection rate among Mexican children fed attenuated poliovirus vaccines. a) Effect of pre-existing poliomyelitis antibody. b) Interfering role of other enteroviruses. In: Proceedings of the First International Conference on Live Poliovirus Vaccines, Scientific Publication No. 44. Pan American Sanitary Bureau, 1959:272-85.
9. Japan Live Poliovaccine Research Commission. Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children. Jpn J Med Sci Biol 1966; 19: 277-91.
10. Triki H, Abdallah MV, Ben Aissa R, et al. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine 1997; 15:1123-9.
11. Mahmoud AA, Imam IZ, Abozid SS, El Mished AM, Mitkis FA. The influence of bacillary dysentery on the efficiency of oral poliovaccine in Egypt. Gaz Egypt Paediatr Assoc 1976; 24:82-91.
12. Posey DL, Linkins RW, Oliveria MJ, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997; 175:S258-63.
13. Kok PW, Leeuwenburg J, Tukei P, et al. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bull World Health Organ 1992; 70:93-103.
14. John TJ, Christopher S. Oral polio vaccination of children in the tropics. III. Intercurrent enterovirus infections, vaccine virus take and antibody response. Am J Epidemiol 1975; 102:422-8.
15. Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. JAMA 1960; 173:1521-6.
16. Korpe PS, PetriWA Jr. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 2012; 18:328-36.
17. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med 2009; 6:e1000097.
18. Ramos-Alvarez M. Discussion. In: First International Conference on Vaccines against Viral and Rickettsial Diseases of Man: Papers Presented and Discussions Held, Washington, DC, 7-11 November 1966, Scientific Publication No. 148. Pan American Sanitary Bureau, 1967: 213-4.
19. Urasawa S. Studies on the interference between group B coxsackie viruses and polioviruses. 2. Comparisons of the effects of coxsackie B 5 virus on the immunizations with mono-and polyvalent live poliovirus vaccines. Sapporo Igaku Zasshi 1964; 26:8-14.
20. WHO. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis 1995; 171:1097-106.
21. Plot Digitizer 2.6.2. http://plotdigitizer.sourceforge.net. Accessed 24 May 2013.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
23. Cheung MWL. Modeling dependent effect sizes with three-level metaanalyses: a structural equation modeling approach. Psychol Methods 2013; doi:10.1037/a0032968.
24. World Bank. Country and lending groups. http://data.worldbank.org/about/ country-classifications/country-and-lending-groups. Accessed 25 April 2013.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
26. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria, R Foundation for Statistical Computing, 2010. ISBN: 3-900051-07-0.
27. Fang-Cho K. Serologic response in children of 0 to 7 years of age to oral administration of Sabin live poliomyelitis vaccine. In: Oral Live Poliovirus Vaccine: Papers presented at the IVth Scientific Conference of the Institute of Poliomyelitis and Virus Encephalitis and the International Symposium on Live Poliovirus Vaccine, 1960:261-6.
28. Levine S, Goldblum N. Virological findings and antibody response of infants fed multiple type oral poliomyelitis vaccine. A preliminary report. In: Proceedings of the Second International Conference on Live Poliovirus Vaccines, Scientific Publication No. 50. Pan American Sanitary Bureau, 1960:270-6.
29. Voroshilova MK, Zhevandrova VI, Koroleva GA, Tolskaya EA, Taranova GP. The effect of enterovirus carriage on results of oral immunization with live poliovirus vaccine from Sabin strains. In: Oral Live Poliovirus Vaccine: Papers presented at the IVth Scientific Conference of the Institute of Poliomyelitis and Virus Encephalitis and the International Symposium on Live Poliovirus Vaccine, 1960:560-73.
30. Domok I, Molnar E, Jancso A. Virus excretion after mass vaccination with attenuated polioviruses in Hungary. Br Med J 1961; 1:1410-7.
31. Ramos-Alvarez M. Use of the live Sabin poliomyelitis vaccine in Mexico. Preliminary basic studies. Bol Med Hosp Infant Mex 1961; 18:13-23.
32. Dardanoni L, Brancato P, Gullo A. Recent research on the take of attenuated poliomyelitis virus (type I, Sabin LSc strain) in children living in a community with a high level of enteroviral infections. Riv Ist Sieroter Ital 1962; 37:428-43.
33. Ingram VG, Lepow ML,Warren RJ, Robbins FC. Behavior of Sabin type 1 attenuated poliovirus in an infant population infected with ECHO 14 virus. Pediatrics 1962; 29:174-80.
34. Paul JR, Horstmann DM, Riordan JT, et al. An oral poliovirus vaccine trial in Costa Rica. Bull World Health Organ 1962; 26:311-29.
35. Paul JR, Horstmann DM, Riordan JT, Opton EM, Green RH. The capacity of live attenuated polioviruses to cause human infection and to spread within families. In: Proceedings of the Second International Conference on Live Poliovirus Vaccines, Scientific Publication No. 50. Pan American Sanitary Bureau, 1960:174-84.
36. Spano C, Dardanoni L. Studies on circulation of enterovirus in samples of the population subjected to oral antipoliomyelitis vaccination. Riv Ist Sieroter Ital 1965; 40:169-78.
37. Urasawa S. Studies on the interference between group B coxsackie viruses and polioviruses. I. The interference with attenuated polioviruses by coxsackie B5 virus in man. Sapporo Igaku Zasshi 1964; 25: 247-57.
38. Takatsu T. Administration of attenuated poliovirus vaccine. Shonika Shinryo 1962; 25:1316-21.
39. Nardi GE, Bellelli E, Trombetta N, Vitali NA. Oral polio revaccination and interference. Ann Sclavo 1966; 8:700-8.
40. Monaci V, Vitali MA, Nardi G, Bellelli E, Trombetta N, Bassanetti F. Revaccination with Sabin's attenuated trivalent oral polio vaccine in some areas of northern Italy. Ann Sclavo 1965; 7:341-58.
41. Sureau P, Mesbah OA, Forthomme G. Second oral poliomyelitis vaccination campaign in Laghouat in 1966. 2. Virological and serological controls of vaccination. Arch Inst Pasteur Alg 1966; 44:23-36.
42. Faden H, Duffy L. Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines. Am J Dis Child 1992; 146:1320-3.
43. Myaux JA, Unicomb L, Besser RE, et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatr Infect Dis J 1996; 15:204-9.
44. Maldonado YA, Pena-Cruz V, de la Luz Sanchez M, et al. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. J Infect Dis 1997; 175:545-53.
45. Swartz TA, Skalska P, Gerichter CG, Cockburn WC. Routine administration of oral polio vaccine in a subtropical area. Factors possibly influencing sero-conversion rates. J Hyg 1972; 70:719-26.
46. Swartz TA, Skalska P, Gerichter CB, Cockburn WC. Non-polio virus interference with oral polio vaccine immunization: possible influence of physical climate and socio-economic status. Adv Exp Med Biol 1972; 31:237-40.
47. Jegouic S, Joffret ML, Blanchard C, et al. Recombination between polioviruses and co-circulating Coxsackie Aviruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLOS Pathog 2009; 5: e1000412.
48. Drozdov SG, Shirman GA. Interaction of viruses in the intestinal tract of man. I. Interference between wild and vaccine poliovirus strains. Acta Virol 1961; 5:210-9.
49. Lee LH, Phillips CA, South MA, Melnick JL, Yow MD. Enteric virus isolation in different cell cultures. Bull World Health Organ 1965; 32:657-63.
50. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209-22.